Pharmaceutical Market: Greece, Denmark, Bahrain, Sri Lanka, Czech Republic by Researchmoz.us

News provided by

Apr 16, 2014, 07:30 ET

ALBANY, New York, April 16, 2014 /PRNewswire/ --

ResearchMoz.us includes new market research report "The Pharmaceutical Market: Greece, Denmark, Bahrain, Sri Lanka and Czech Republic "to its huge collection of research reports.

The macroenvironment for the Danish pharmaceutical industry is improving.The centre-left coalition, of the Social Democratic Party, the Socialist People's Party and the Social Liberal Party, took office in October 2011. Denmark suffered a deep recession and economic recovery is stalling with negative GDP growth projected for 2012. Denmark has an ageing population, and the Economist Intelligence Unit projects that the population aged 65 and over will constitute more than one-fifth of the total population by 2016. As a result, healthcare is increasingly focused on preventative care and there will be a continuing demand for new therapies so that patients can be treated more effectively.

The Pharmaceutical Market: Greece

Headline Expenditure Projections

Pharmaceuticals: EUR6.72bn (US$9.35bn) in 2011 to EUR5.92bn (US$7.52bn) in 2012;(http://www.researchmoz.us/the-pharmaceutical-market-greece-report.html )

-12.0% in local currency terms and -19.6% in US dollar terms. Forecast broadly maintained from Q3 12.

Healthcare: EUR21.80bn (US$30.31bn) in 2011 to EUR20.34bn (US$25.83bn) in 2012; -6.7% in local currency terms and -14.8% in US dollar terms. Forecast broadly stable from Q3 12.

Medical devices: EUR670mn (US$931mn) in 2011 to EU607mn (US$771mn) in 2012; -9.3% in local currency terms and -17.1% in US dollar terms. Forecast unchanged from Q3 12.

Risk/RewardRating

In our latest RRRs, we have revised down our assessment of the Greek market, with a downgrade to the industry risk score as a result of broadly unfavourable operating conditions worsening, specifically re-payment terms, which we have criticised previously, and our assessment of whether innovative drugmakers would want to launch new products on the market.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Latest And Related Report Of Pharmaceutical Countrywise

The Pharmaceutical Market: Denmark

The Pharmaceutical Market: Bahrain

The Pharmaceutical Market: Sri Lanka

The Pharmaceutical Market: Czech Republic

Table of Contents

BMI Industry View 7

SWOT 10

Political 12

Economic 13

Business Environment 14

Industry Forecast 15

Pharmaceutical Market Forecast 15

Table: Greece Pharmaceutical Sales, Historical Data And Forecasts 18

Healthcare Market Forecast 19

Table: Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017 20

Table: Healthcare Governmental Indicators, 2009-2017 20

Table: Healthcare Private Indicators, 2009-2017 21

Economic Analysis 21

Table: Economic Activity 25

Prescription Drugs Market Forecast 26

Table: Prescription Drug Sales Indicators, 2009-2017 27

Patented Drugs Market Forecast 28

Table: Patented Drug Sales, 2009-2017 29

Generic Drugs Market Forecast 30

Table: Generic Drug Sales, 2009-2017 31

OTC Medicine Market Forecast 32

Table: OTC Medicine Sales, 2009-2017 33

Table: OTC Medicine Sales Breakdown, 2007-2010 33

Pharmaceutical Trade Forecast 34

Table: Pharmaceutical Trade Forecast, 2009-2017 35

Key Risks To BMI's Forecast Scenario 36

Industry Risk Reward Ratings 37

Table: Central And Eastern Europe Pharmaceutical Risk/Reward Ratings, Q213 37

Rewards 38

Risks 39

Market Overview 41

Industry Trends And Developments 44

Epidemiology 44

Healthcare Sector 45

Infrastructure 49

Table: Inpatient Facilities And Beds By Speciality, 2008 49

Table: Outpatient Facilities And Beds By Region, 2008 50

Drug Retailing 51

Table: Pharmacies By Region, 2007-2009 51

Regulatory Development 52

Regulatory Regime 52

Intellectual Property Regime 53

Pricing Regime 53

Table: Quarterly Total Sales Volume Per Medicinal Product (additional to 9% of the current decision rebate amount) 55

Reimbursement Regime 58

Competitive Landscape 61

Company Profile 63

Abbott Laboratories 63

Alapis Pharma 65

Elpen 68

Genesis Pharma 70

GlaxoSmithKline 72

Kleva 74

Lavipharm 76

Merck Sharpe & Dohme 78

Novartis 80

Sanofi 82

Pfizer 84

Pharmathen 86

Vianex 88

Demographic Forecast 90

Table: Greece's Population By Age Group, 1990-2020 ('000) 91

Table: Greece's Population By Age Group, 1990-2020 (% of total) 92

Table: Greece's Key Population Ratios, 1990-2020 93

Table: Greece's Rural And Urban Population, 1990-2020 93

Methodology 94

Risk/Reward Ratings Methodology 94

Ratings Overview 95

Table: Pharmaceutical Business Environment Indicators 95

Weighting 96

Table: Weighting Of Components 96

Explorer More Espicom Market Research Reports Publishing Reports At: http://www.researchmoz.us/publisher/espicom-60.html

About Us

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

90 Sate Street, Suite 700

Albany, NY 12207

Website@ http://www.researchmoz.us/
Blog: http://usresearch.blogspot.com/

Email: [email protected]

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-997-4948

SOURCE ResearchMoz